Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Maurer Barbara,

** = Publikationen gelistet in SCI/SSCI/Pubmed

2021

Zeitschriftenaufsatz

** Doma, E; Mayer, IM; Brandstoetter, T; Maurer, B; Grausenburger, R; Menzl, I; Zojer, M; Hoelbl-Kovacic, A; Carlsson, L; Heller, G; Kollmann, K; Sexl, V (2021): A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation. Blood Adv. 2021; 5(1):39-53

2020

** Kadekar, D; Agerholm, R; Rizk, J; Neubauer, HA; Suske, T; Maurer, B; Viñals, MT; Comelli, EM; Taibi, A; Moriggl, R; Bekiaris, V (2020): The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. J Clin Invest. 2020; 130(5):2496-2508

** La Sala, G; Michiels, C; Kükenshöner, T; Brandstoetter, T; Maurer, B; Koide, A; Lau, K; Pojer, F; Koide, S; Sexl, V; Dumoutier, L; Hantschel, O (2020): Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains. Nat Commun. 2020; 11(1):4115
Open Access Logo

** Maurer, B; Brandstoetter, T; Kollmann, S; Sexl, V; Prchal-Murphy, M (2020): Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system. Haematologica. 2020; haematol.2020.256313
Open Access Logo [Article in Press]

** Maurer, B; Nivarthi, H; Wingelhofer, B; Pham, HTT; Schlederer, M; Suske, T; Grausenburger, R; Schiefer, AI; Prchal-Murphy, M; Chen, D; Winkler, S; Merkel, O; Kornauth, C; Hofbauer, M; Hochgatterer, B [and 23 others] (2020): High activation of STAT5A drives peripheral T-cell lymphoma and leukemia. Haematologica. 2020; 105(2):435-447
Open Access Logo

** Schmoellerl, J; Barbosa, IAM; Eder, T; Brandstoetter, T; Schmidt, L; Maurer, B; Troester, S; Pham, HTT; Sagarajit, M; Ebner, J; Manhart, G; Aslan, E; Terlecki-Zaniewicz, S; Van der Veen, C; Hoermann, G [and 12 others] (2020): CDK6 is an essential direct target of NUP98-fusion proteins in acute myeloid leukemia. Blood. 2020; 136(4):387-400

2019

** Klein, K; Witalisz-Siepracka, A; Maurer, B; Prinz, D; Heller, G; Leidenfrost, N; Prchal-Murphy, M; Suske, T; Moriggl, R; Sexl, V (2019): STAT5BN642H drives transformation of NKT cells: a novel mouse model for CD56+ T-LGL leukemia. Leukemia. 2019; 33(9):2336-2340
Open Access Logo

** Kollmann, S; Grundschober, E; Maurer, B; Warsch, W; Grausenburger, R; Edlinger, L; Huuhtanen, J; Lagger, S; Hennighausen, L; Valent, P; Decker, T; Strobl, B; Mueller, M; Mustjoki, S; Hoelbl-Kovacic, A; Sexl, V (2019): Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia. Leukemia. 2019; 33(7):1583-1597
Open Access Logo

** Maurer, B; Kollmann, S; Pickem, J; Hoelbl-Kovacic, A; Sexl, V (2019): STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia. Cancers (Basel). 2019; 11(11):1726
Open Access Logo

** Uras, IZ; Maurer, B; Nivarthi, H; Jodl, P; Kollmann, K; Prchal-Murphy, M; Milosevic Feenstra, JD; Zojer, M; Lagger, S; Grausenburger, R; Grabner, B; Holly, R; Kavirayani, A; Bock, C; Gisslinger, H [and 3 others] (2019): CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks. Blood 133(15): 1677-1690.
Open Access Logo

Kongressbeitrag in einer Zeitschrift

** Maurer, B; Uras, IZ; Kollmann, S; Jodl, P; Kollmann, K; Prchal-Murphy, M; Nivarthi, H; Zojer, M; Grausenburger, R; Kralovics, R; Sexl, V (2019): CDK6 is an essential signaling node in JAK2V617F-mutant MPN. 44th FEBS Congress, From Molecules to Living Systems, Krakow, Poland, Jul 6‐11, 2019. FEBS Open Bio (9), S1 355-356.
Open Access Logo

2018

Zeitschriftenaufsatz

** Orlova, A; Wingelhofer, B; Neubauer, HA; Maurer, B; Berger-Becvar, A; Keserű, GM; Gunning, PT; Valent, P; Moriggl, R (2018): Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas. Expert Opin Ther Targets. 2018; 22(1):45-57
Open Access Logo

** Pham, HTT; Maurer, B; Prchal-Murphy, M; Grausenburger, R; Grundschober, E; Javaheri, T; Nivarthi, H; Boersma, A; Kolbe, T; Elabd, M; Halbritter, F; Pencik, J; Kazemi, Z; Grebien, F; Hengstschläger, M [and 9 others] (2018): STAT5BN642H is a driver mutation for T cell neoplasia. J Clin Invest. 2018; 128(1):387-401
Open Access Logo

** Schrader, A; Crispatzu, G; Oberbeck, S; Mayer, P; Pützer, S; von Jan, J; Vasyutina, E; Warner, K; Weit, N; Pflug, N; Braun, T; Andersson, EI; Yadav, B; Riabinska, A; Maurer, B [and 21 others] (2018): Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018; 9(1):697
Open Access Logo

** Uras, IZ; Maurer, B; Nebenfuehr, S; Zojer, M; Valent, P; Sexl, V (2018): Therapeutic Vulnerabilities in FLT3 -Mutant AML Unmasked by Palbociclib. Int J Mol Sci. 2018; 19(12): 3987.
Open Access Logo

** Wingelhofer, B; Maurer, B; Heyes, EC; Cumaraswamy, AA; Berger-Becvar, A; de Araujo, ED; Orlova, A; Freund, P; Ruge, F; Park, J; Tin, G; Ahmar, S; Lardeau, CH; Sadovnik, I; Bajusz, D [and 6 others] (2018): Pharmacologic inhibition of STAT5 in acute myeloid leukemia. Leukemia. 2018; 32(5):1135-1146
Open Access Logo

2017

** Fragiadaki, M; Lannoy, M; Themanns, M; Maurer, B; Leonhard, WN; Peters, DJ; Moriggl, R; Ong, AC (2017): STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney Int. 2017; 91(3):575-586

** Maurer, B; Farlik, M; Sexl, V (2017): It is a differentiation game: STAT5 in a new role. Cell Death Differ. 2017; 24(6):953-954
Open Access Logo

2016

** Jayavelu, AK; Müller, JP; Bauer, R; Böhmer, SA; Lässig, J; Cerny-Reiterer, S; Sperr, WR; Valent, P; Maurer, B; Moriggl, R; Schröder, K; Shah, AM; Fischer, M; Scholl, S; Barth, J [and 7 others] (2016): NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia. 2016; 30(2):473-483

Kongressbeitrag in einer Zeitschrift

** Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Schlederer, M; Pham, HTT; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Muller, M; Rülicke, T; Moriggl, R (2016): Activated Stat5 Drives Peripheral T Cell Lymphomas. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 567-567.

2015

** Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Prochazkova, J; Schlederer, M; Pham, H; Loizou, JI; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Müller, M [and 2 others] (2015): An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 77-77.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit